相关产品推荐更多 >
![BioSIM 人 ACVR2B & Fc 融合蛋白 (罗特西普),生物类似药,科研用途 [ CAS: 1373715-00-4] 1mg](https://img1.dxycdn.com/p/s14/2025/1109/337/8404950979567947891.jpg!wh200)
BioSIM 人 ACVR2B & Fc 融合蛋白 (罗特西普),生物类似药,科研用途 [ CAS: 1373715-00-4] 1mg
询价![BioSIM 人 TRAIL & Fc 融合蛋白 (依托奈明α),生物类似药,科研用途 [ CAS: 1820660-69-2] 5mg](https://img1.dxycdn.com/p/s14/2025/1109/337/8404950979567947891.jpg!wh200)
BioSIM 人 TRAIL & Fc 融合蛋白 (依托奈明α),生物类似药,科研用途 [ CAS: 1820660-69-2] 5mg
询价![BioSIM 人 CD24 & Fc 融合蛋白 (依瑞莫德α),生物类似药,科研用途 [ CAS: 2574508-57-7] 5mg](https://img1.dxycdn.com/p/s14/2025/1109/337/8404950979567947891.jpg!wh200)
BioSIM 人 CD24 & Fc 融合蛋白 (依瑞莫德α),生物类似药,科研用途 [ CAS: 2574508-57-7] 5mg
询价![BioSIM 人 IL-1 Trap (利纳西普),生物类似药,科研用途 [ CAS: 501081-76-1] 5mg](https://img1.dxycdn.com/p/s14/2025/1109/337/8404950979567947891.jpg!wh200)
BioSIM 人 IL-1 Trap (利纳西普),生物类似药,科研用途 [ CAS: 501081-76-1] 5mg
询价![BioSIM 人 Adnectin & Fc 融合蛋白 (他特西普α),生物类似药,科研用途 [ CAS: 1580555-26-5] 1mg](https://img1.dxycdn.com/p/s14/2025/1109/337/8404950979567947891.jpg!wh200)
BioSIM 人 Adnectin & Fc 融合蛋白 (他特西普α),生物类似药,科研用途 [ CAS: 1580555-26-5] 1mg
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
为确保适当的储存,请避免反复冻融循环。如需短期使用(1-2周),请在4℃条件下保存;如需保存长达12个月,请在-20℃条件下储存。对于长期储存,请在-80℃条件下保存。
- 保质期:
为确保适当的储存,请避免反复冻融循环。如需短期使用(1-2周),请在4℃条件下保存;如需保存长达12个月,请在-20℃条件下储存。对于长期储存,请在-80℃条件下保存。
- 英文名:
BioSIM Human anti-PD-L1 x TGF-β trap fusion protein (Bintrafusp Alfa Biosimilar), Research Grade
- 库存:
999
- 供应商:
亚科因(Abbkine)
- 规格:
1mg
BioSIM 人 anti-PD-L1 x TGF-β trap 融合蛋白 (必特芙普α),生物类似药,科研用途
CAS号:1918149-01-5
产品核心基础信息
- 英文全称:BioSIM Human anti-PD-L1 x TGF-β trap fusion protein (Bintrafusp Alfa Biosimilar), Research Grade
- 供应商:InvivoCrown
- 产品货号:SIM0614-1mg
- 单份规格:1mg
- 产品类型:重组融合蛋白
生产工艺与背景
本重组生物类似药遵循无动物源生产体系,全程采用体外无蛋白细胞培养技术,从生产环境到原料均避免动物源性成分引入,降低交叉污染风险。
产品经多步纯化工艺精制,核心步骤包含蛋白A/G亲和色谱,配合后续精制工序,确保目标蛋白纯度与活性满足科研级实验要求。
表达系统与缓冲液参数
表达系统
重组蛋白由哺乳动物细胞表达系统生产,可模拟天然蛋白的翻译后修饰(如糖基化等),更贴近体内生理状态,适合免疫相关机制研究。
缓冲液组成
- 基础缓冲液:PBS(磷酸盐缓冲液)
- pH值:7.4(生理环境相近)
- 添加剂:不含稳定剂、防腐剂
科研应用方向
本产品聚焦肿瘤免疫领域,适用于以下研究场景:
- 胆管癌的免疫调控机制研究
- 肺癌(含非小细胞肺癌NSCLC)的靶点相互作用研究
- anti-PD-L1与TGF-β trap双功能蛋白的生物学活性验证
保存与稳定性建议
为维持产品活性,需严格遵循储存规范:
- 短期使用(1-2周):4℃避光保存(避免反复开盖)
- 中期保存(≤12个月):-20℃避光保存(建议分装为单次使用量)
- 长期保存:-80℃避光保存(最佳长期稳定性条件)
- 关键注意:严禁反复冻融循环,以防蛋白构象改变导致活性下降
注意:以上信息可能随着产品优化升级等因素产生变动,具体信息请咨询亚科因公司。

BioSIM Human anti-PD-L1 x TGF-β trap fusion protein (Bintrafusp Alfa Biosimilar), for Research Use
CAS No.:1918149-01-5
Core Product Information
- Full English Name:BioSIM Human anti-PD-L1 x TGF-β trap fusion protein (Bintrafusp Alfa Biosimilar), Research Grade
- Supplier:InvivoCrown
- Catalog No.:SIM0614-1mg
- Package Size:1mg
- Product Type:Recombinant Fusion Protein
Manufacturing Process and Background
This recombinant biosimilar follows an animal-free production system, using in vitro protein-free cell culture technology throughout the process. From the production environment to raw materials, animal-derived components are avoided to reduce the risk of cross-contamination.
The product is purified through a multi-step purification process, with key steps including Protein A/G affinity chromatography, combined with subsequent refinement procedures to ensure the purity and activity of the target protein meet research-grade experimental requirements.
Expression System and Buffer Parameters
Expression System
The recombinant protein is produced using a mammalian cell expression system, which can simulate post-translational modifications of natural proteins (such as glycosylation), making it closer to in vivo physiological conditions and suitable for immune mechanism-related research.
Buffer Composition
- Base Buffer:PBS (Phosphate Buffered Saline)
- pH Value:7.4 (similar to physiological environment)
- Additives:Free of stabilizers and preservatives
Research Applications
This product focuses on the field of tumor immunity and is suitable for the following research scenarios:
- Research on immunomodulatory mechanisms in cholangiocarcinoma
- Research on target interactions in lung cancer (including non-small cell lung cancer NSCLC)
- Biological activity verification of the bifunctional anti-PD-L1 and TGF-β trap protein
Storage and Stability Recommendations
To maintain product activity, storage guidelines must be strictly followed:
- Short-term use (1-2 weeks):Store at 4°C protected from light (avoid repeated opening)
- Medium-term storage (≤12 months):Store at -20°C protected from light (aliquoting into single-use portions is recommended)
- Long-term storage:Store at -80°C protected from light (optimal condition for long-term stability)
- Key Note:Repeated freeze-thaw cycles are strictly prohibited to prevent conformational changes in the protein leading to decreased activity
Note: The above information may change due to factors such as product optimization and upgrades. Please consult Yaokein Company for specific details.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验
技术资料暂无技术资料 索取技术资料




